Correlation between C9ORF72 mutation and neurodegenerative diseases: A comprehensive review of the literature

Int J Med Sci. 2021 Jan 1;18(2):378-386. doi: 10.7150/ijms.53550. eCollection 2021.

Abstract

Chromosome 9 open reading frame 72 (C9ORF72) encodes a 54-kDa protein with unknown function that is expressed at high levels in the central nervous system. The C9ORF72 hexanucleotide amplification is one of the most recently discovered repetitive amplification diseases related to neurodegeneration. Its association with amyotrophic lateral sclerosis/frontotemporal dementia (ALS/FTD) spectrum diseases has been fully established, although a causative role for C9ORF72 in Alzheimer's disease (AD) and Parkinson's disease (PD) remains to be established. Therefore, in this article, we will review the evidence for C9ORF72 as a causative factor in neurodegenerative diseases, the underlying mechanisms, and the potential for targeting C9ORF72 as a strategy to alleviate neurodegenerative disease progression.

Keywords: Alzheimer's disease; Amyotrophic lateral sclerosis; C9ORF72; Frontotemporal dementia; Neurodegenerative diseases; Parkinson's disease.

Publication types

  • Review

MeSH terms

  • Animals
  • C9orf72 Protein / antagonists & inhibitors
  • C9orf72 Protein / genetics*
  • Disease Models, Animal
  • Disease Progression
  • Humans
  • Mutation
  • Neurodegenerative Diseases / diagnosis
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / genetics*
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use

Substances

  • C9orf72 Protein
  • C9orf72 protein, human
  • Neuroprotective Agents